Trastuzumab Deruxtecan Shows Improvement in PFS in Patients

The investigators note that additional research is needed to confirm positive overall survival trends in this patient population.

Related Keywords

Ken Takeshita , Sebastian Kaulitzki , Daiichi Sankyo , Susan Galbraith , Astrazeneca , Trastuzumab Deruxtecan , Hormone Receptor Positive , Metastatic Breast Cancer , Preview Data , Regulatory Insights , New Metastatic Breast Cancer ,